Lineage Cell Therapeutics appoints George Samuel as general counsel
Lineage Cell Therapeutics, a clinical-stage biotechnology company developing novel cell therapies for unmet medical needs appointed George Samuel (pictured) as Lineage’s general counsel and corporate secretary. Samuel will lead the company’s legal operations, bringing extensive corporate, transactional, intellectual property and commercial expertise which spans nearly 15 years across the life sciences and technology sectors as well as in private practice.
Samuel joined Lineage from Lytx, where he served as director, senior counsel counsel, managing the commercial legal operations for an international video telematics SaaS company. Prior to that, he served as VP, general counsel and corporate secretary for Cardiff Oncology, a clinical-stage biotechnology company. Samuel also practiced corporate law at Cooley, DLA Piper and Winston & Strawn.